» Articles » PMID: 33761951

Neuronal Cell-based High-throughput Screen for Enhancers of Mitochondrial Function Reveals Luteolin As a Modulator of Mitochondria-endoplasmic Reticulum Coupling

Abstract

Background: Mitochondrial dysfunction is a common feature of aging, neurodegeneration, and metabolic diseases. Hence, mitotherapeutics may be valuable disease modifiers for a large number of conditions. In this study, we have set up a large-scale screening platform for mitochondrial-based modulators with promising therapeutic potential.

Results: Using differentiated human neuroblastoma cells, we screened 1200 FDA-approved compounds and identified 61 molecules that significantly increased cellular ATP without any cytotoxic effect. Following dose response curve-dependent selection, we identified the flavonoid luteolin as a primary hit. Further validation in neuronal models indicated that luteolin increased mitochondrial respiration in primary neurons, despite not affecting mitochondrial mass, structure, or mitochondria-derived reactive oxygen species. However, we found that luteolin increased contacts between mitochondria and endoplasmic reticulum (ER), contributing to increased mitochondrial calcium (Ca) and Ca-dependent pyruvate dehydrogenase activity. This signaling pathway likely contributed to the observed effect of luteolin on enhanced mitochondrial complexes I and II activities. Importantly, we observed that increased mitochondrial functions were dependent on the activity of ER Ca-releasing channels inositol 1,4,5-trisphosphate receptors (IPRs) both in neurons and in isolated synaptosomes. Additionally, luteolin treatment improved mitochondrial and locomotory activities in primary neurons and Caenorhabditis elegans expressing an expanded polyglutamine tract of the huntingtin protein.

Conclusion: We provide a new screening platform for drug discovery validated in vitro and ex vivo. In addition, we describe a novel mechanism through which luteolin modulates mitochondrial activity in neuronal models with potential therapeutic validity for treatment of a variety of human diseases.

Citing Articles

Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder.

Loi M, Valenti F, Medici G, Mottolese N, Candini G, Bove A Int J Mol Sci. 2025; 26(5).

PMID: 40076840 PMC: 11900000. DOI: 10.3390/ijms26052204.


Structural and functional studies of the VAPB-PTPIP51 ER-mitochondria tethering proteins in neurodegenerative diseases.

Blair K, Martinez-Serra R, Gosset P, Martin-Guerrero S, Morotz G, Atherton J Acta Neuropathol Commun. 2025; 13(1):49.

PMID: 40045432 PMC: 11881430. DOI: 10.1186/s40478-025-01964-7.


Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms.

Anchimowicz J, Zielonka P, Jakiela S Int J Mol Sci. 2025; 26(1.

PMID: 39796234 PMC: 11720160. DOI: 10.3390/ijms26010380.


Luteolin suppresses oral carcinoma 3 (OC3) cell growth and migration via modulating polo-like kinase 1 (PLK1) expression and cellular energy metabolism.

Gao P, Zhang W, Lin Y, Lu R, Lou Z, Lu G J Zhejiang Univ Sci B. 2023; 24(12):1151-1158.

PMID: 38057271 PMC: 10710912. DOI: 10.1631/jzus.B2300200.


Insight into endoplasmic reticulum-mitochondria contacts in human amyotrophic lateral sclerosis.

Hartopp N, Markovinovic A, Miller C, Gomez-Suaga P Neural Regen Res. 2023; 19(7):1407-1408.

PMID: 38051870 PMC: 10883496. DOI: 10.4103/1673-5374.387988.


References
1.
Kang K, Piao M, Hyun Y, Zhen A, Cho S, Ahn M . Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells. Exp Mol Med. 2019; 51(4):1-14. PMC: 6465248. DOI: 10.1038/s12276-019-0238-y. View

2.
Miquel E, Cassina A, Martinez-Palma L, Souza J, Bolatto C, Rodriguez-Bottero S . Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis. Free Radic Biol Med. 2014; 70:204-13. DOI: 10.1016/j.freeradbiomed.2014.02.019. View

3.
Tsilioni I, Taliou A, Francis K, Theoharides T . Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Transl Psychiatry. 2015; 5:e647. PMC: 5545641. DOI: 10.1038/tp.2015.142. View

4.
De Camilli P . Exocytosis goes with a SNAP. Nature. 1993; 364(6436):387-8. DOI: 10.1038/364387a0. View

5.
Cherubini M, Lopez-Molina L, Gines S . Mitochondrial fission in Huntington's disease mouse striatum disrupts ER-mitochondria contacts leading to disturbances in Ca efflux and Reactive Oxygen Species (ROS) homeostasis. Neurobiol Dis. 2020; 136:104741. DOI: 10.1016/j.nbd.2020.104741. View